Doug Schenkel
Stock Analyst at Wolfe Research
(3.60)
# 781
Out of 4,944 analysts
67
Total ratings
53.06%
Success rate
33.71%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $34.15 | -6.30% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $72.45 | -17.18% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $68.25 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $28.55 | +110.16% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $22.71 | +23.29% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $245.34 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $125.45 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $2.66 | - | 1 | Nov 14, 2024 | |
| DHR Danaher | Upgrades: Outperform | $285 | $210.00 | +35.71% | 2 | Oct 31, 2024 | |
| BRKR Bruker | Downgrades: Peer Perform | n/a | $33.97 | - | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $118.54 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $52 | $48.82 | +5.49% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $13.50 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $99.65 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $44.04 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $483.44 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.74 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $89.35 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.27 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $12.96 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $59.48 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $157.10 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $292.34 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.16 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $2.98 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.29 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.20 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.12 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.26 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $3.65 | +393.15% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $11.04 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $309.68 | -70.94% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.60 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $187.38 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $79.52 | -79.88% | 2 | Sep 28, 2017 |
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $34.15
Upside: -6.30%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $72.45
Upside: -17.18%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $68.25
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $28.55
Upside: +110.16%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $22.71
Upside: +23.29%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $245.34
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $125.45
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $2.66
Upside: -
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $210.00
Upside: +35.71%
Bruker
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $33.97
Upside: -
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $118.54
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $52
Current: $48.82
Upside: +5.49%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $13.50
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $99.65
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $44.04
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $483.44
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $5.74
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $89.35
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.27
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $12.96
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $59.48
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $157.10
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $292.34
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.16
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $2.98
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.29
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $7.20
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.12
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $7.26
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $3.65
Upside: +393.15%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $11.04
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $309.68
Upside: -70.94%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $4.60
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $187.38
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $79.52
Upside: -79.88%